University of Cincinnati Apr 10 2026 The University of Cincinnati has enrolled the first patients in a new clinical trial that will test the effectiveness of an investigational drug for prosthetic joint infections (PJI). T. Toan Le, MD, a professor in the Department of Orthopaedic Surgery in the College of Medicine, has now enrolled two patients in Peptilogics' RETAIN trial. About 5 million joint replacements are performed each year in the United States and Europe. Peptilogics, a surgical